98 related articles for article (PubMed ID: 6436119)
1. An evaluation of the stability of Brucella abortus strain 19 reduced dosage lyophilized vaccines produced by different methods.
Angus RD
Dev Biol Stand; 1984; 56():659-78. PubMed ID: 6436119
[TBL] [Abstract][Full Text] [Related]
2. Survival of Brucella abortus strain RB51 lyophilized and as liquid vaccine under different storage conditions.
Capsel RL; Olsen SC; Cheville NF; Thoen CO
Biologicals; 2000 Dec; 28(4):209-15. PubMed ID: 11237356
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of five mediums for the stabilization of Brucella abortus strain 19 dessicated by lyophilization.
Angus RD; Love EL; Pietz DE
Dev Biol Stand; 1976 Oct; 36():307-12. PubMed ID: 829491
[TBL] [Abstract][Full Text] [Related]
4. Freeze-drying of brucella vaccine strain B 19.
Valette L; Stellmann C; Précausta P; Desmettre P; Le Pemp M
Dev Biol Stand; 1976 Oct; 36():313-22. PubMed ID: 829492
[TBL] [Abstract][Full Text] [Related]
5. [Effect of temperature and degree of vacuum on the conservation of freeze-dried Brucella abortus strain 19 vaccine].
García-Carrillo C
Zentralbl Veterinarmed B; 1982 Feb; 29(1):57-66. PubMed ID: 6807032
[No Abstract] [Full Text] [Related]
6. [Studies on the preparation of a lyophilized Brucella abortus live vaccine ("Buck 19"). 1. On the effect of various stabilizators on the number of live cells].
Boden W
Arch Exp Veterinarmed; 1965 Apr; 19(1):281-7. PubMed ID: 4953584
[No Abstract] [Full Text] [Related]
7. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
Olsen SC
Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of immunotherapy by live Brucella abortus (strain 19 BA) in cancer patients.
Dazord L; Martin A; Le Rest R; Le Prisé PY; Larzul JJ; Gandhour C; David C; Toujas L
Cancer Treat Rep; 1984 Feb; 68(2):417-8. PubMed ID: 6421482
[TBL] [Abstract][Full Text] [Related]
9. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
Dénes B
Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
[TBL] [Abstract][Full Text] [Related]
10. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
Woodard LF; Toone NM; Jasman RL
Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle.
Palmer MV; Olsen SC; Cheville NF
Am J Vet Res; 1997 May; 58(5):472-7. PubMed ID: 9140553
[TBL] [Abstract][Full Text] [Related]
12. Theoretical, practical and statistical basis for a general control method of activity for anti-Brucella vaccines.
Bosseray N; Plommet AM; Plommet M
Dev Biol Stand; 1984; 56():257-70. PubMed ID: 6489617
[TBL] [Abstract][Full Text] [Related]
13. [Cell survival of the Brucella abortus strain 19 vaccine during the lyophilization process according to the vehicle used].
García-Carrillo C
Rev Argent Microbiol; 1981; 13(1):31-4. PubMed ID: 6810408
[TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
15. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
16. [Effect of temperature on preservation of brucella vaccines].
Pilet C; le Garrec Y; Vissac JL; Lanneluc B; Garrido-Calderon N
Dev Biol Stand; 1976; 31():314-22. PubMed ID: 1261745
[TBL] [Abstract][Full Text] [Related]
17. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
18. Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy.
Olsen SC; Bricker B; Palmer MV; Jensen AE; Cheville NF
Res Vet Sci; 1999 Apr; 66(2):101-5. PubMed ID: 10208887
[TBL] [Abstract][Full Text] [Related]
19. Abortion and placentitis in pregnant bison (Bison bison) induced by the vaccine candidate, Brucella abortus strain RB51.
Palmer MV; Olsen SC; Gilsdorf MJ; Philo LM; Clarke PR; Cheville NF
Am J Vet Res; 1996 Nov; 57(11):1604-7. PubMed ID: 8915438
[TBL] [Abstract][Full Text] [Related]
20. Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina.
Wallach JC; Ferrero MC; Victoria Delpino M; Fossati CA; Baldi PC
Clin Microbiol Infect; 2008 Aug; 14(8):805-7. PubMed ID: 18727806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
